Skip to main content

Third Harmonic Bio, Inc.

THRDDelisted Jul 31, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001923840

Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Third Harmonic Bio, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of THRD: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4948−1
Shares36.3M36.1M−284.1K (−0.8%)
Value$149.7M$173.5M+$23.7M (+15.8%)

New holders (8)

Institutions that held Third Harmonic Bio, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to THRD in Q2 2023
InstitutionSharesValue% of portfolio
Goldman Sachs Group Inc16,460$79.2K0.00%
Prelude Capital Management, LLC15,842$76.2K0.01%
Citigroup Inc5,801$27.9K0.00%
Allspring Global Investments Holdings, LLC332$1.60K0.00%
Covestor Ltd207$1.00K0.00%
Glassman Wealth Services149$7170.00%
Toronto Dominion Bank31$00.00%
CWM, LLC44$00.00%

Sold out (9)

Institutions that held Third Harmonic Bio, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of THRD in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
RTW Investments, LP534,687$2.20M
Wellington Management Group LLP312,855$1.29M
Walleye Capital LLC50,000$206.0K
Jefferies Financial Group Inc.21,985$90.6K
XTX Topco Ltd16,116$66.4K
Citadel Advisors LLC10,724$44.2K
Bailard, Inc.10,400$42.8K
LPL Financial LLC10,000$41.2K
Ellevest, Inc.217$894